| 注册
首页|期刊导航|心脑血管病防治|伊伐布雷定联合左西孟旦对射血分数降低的心力衰竭患者的疗效观察

伊伐布雷定联合左西孟旦对射血分数降低的心力衰竭患者的疗效观察

李祯 何改鸿

心脑血管病防治2024,Vol.24Issue(12):24-28,5.
心脑血管病防治2024,Vol.24Issue(12):24-28,5.DOI:10.3969/j.issn.1009-816x.2024.12.007

伊伐布雷定联合左西孟旦对射血分数降低的心力衰竭患者的疗效观察

Efficacy of combined therapy of ivabradine and levosimendan in patients with heart failure with reduced ejection fraction

李祯 1何改鸿1

作者信息

  • 1. 719000 榆林,西安交通大学第一附属医院榆林医院药剂科
  • 折叠

摘要

Abstract

Objective To observe the clinical efficacy of combined therapy of levosimendan and ivabradine in patients with heart failure with reduced ejection fraction(HFrEF).Methods From September 2021 to August 2023,170 HFrEF patients treated at Yulin Hospital,the First Affiliated Hospital of Xi'an Jiaotong University were divided into group A(85 cases)and group B(85 cases)by random number table method.Group A received conventional treatment plus levosimendan injection,while group B was treated with ivabradine hydrochloride tablets on the basis of group A,the treatment lasted for 2 months.Changes in left ventricular function[left ventricular end-diastolic diameter(LVEDD),left ventricular end-systolic diameter(LVESD),left ventricular ejection fraction(LVEF),interventricular septal thickness],heart rate(HR),stroke volume(SV),and index of microcirculatory resistance(IMR)were analyzed before and after treatment.The treatment effectiveness,quality of life,and adverse reactions between the two groups were compared.Results After treatment,LVEDD,LVESD,HR,interventricular septal thickness,and IMR decreased in both groups,while SV and LVEF increased(P<0.05).Group B showed lower post-treatment LVEDD,LVESD,HR,interventricular septal thickness,and IMR and higher SV and LVEF compared to group A(t=2.810,3.460,7.300,6.857,7.950,4.600,3.743;P<0.05).The overall efficacy rate in group B(96.47%)was higher than in Group A(80.00%)(χ2=11.107,P<0.05).Quality of life scores for emotional,physical,social,role,and cognitive functions in Group B were significantly higher than those in Group A(t=22.694,7.072,11.896,10.857,17.426;P<0.05).The incidence of adverse reactions in Group B(8.24%)was lower than that in Group A(20.00%)(χ2=4.852,P<0.05).Conclusion The combination of ivabradine and levosimendan can effectively treat patients with HFrEF,improve their quality of life,and has good safety performance.

关键词

心力衰竭/射血分数降低/伊伐布雷定/左西孟旦

Key words

Heart failure/Reduced ejection fraction/Ivabradine/Levosimendan

引用本文复制引用

李祯,何改鸿..伊伐布雷定联合左西孟旦对射血分数降低的心力衰竭患者的疗效观察[J].心脑血管病防治,2024,24(12):24-28,5.

基金项目

榆林市科协青年人才托举计划项目(20230517) (20230517)

心脑血管病防治

OACSTPCD

1009-816X

访问量0
|
下载量0
段落导航相关论文